Osteoprotegerin, soluble receptor activator of nuclear factor-κB ligand, and subclinical atherosclerosis in children and adolescents with type 1 diabetes mellitus
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.